Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,465,250
+$28,601,450 QoQ
Shares Held
475,000
+163.9% QoQ
Ownership
0.342%
of shares outstanding
% of Portfolio
10.38%
of 13F equity value
Holder Rank
#60
of 477 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Checkpoint Capital L.P. holds $389,759,659 across 6 Biotechnology names. CYTK ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,186,000 | $131,681,580 | |
| 2 | ARGX |
Argenx SE
|
131,283 | $121,800,428 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
410,353 | $76,850,909 | |
| 4 | CYTK |
Cytokinetics Inc
This page
|
475,000 | $40,465,250 | |
| 5 | IRON |
Disc Medicine, Inc.
|
240,125 | $17,562,742 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
75,000 | $1,398,750 |
All Filings in CYTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,465,250 | 475,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,863,800 | 180,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,599,933 | 166,823 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,065,781 | 37,587 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $940,800 | 20,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,647,726 | 466,813 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,294,200 | 190,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,320,900 | 190,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,202,700 | 230,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||